Paradromics implants Connexus in Michigan patient in FDA approved study
Paradromics, a startup competing with Neuralink, has implanted its Connexus brain-computer device in a Michigan patient who has difficulty speaking due to motor neuron disease.
The procedure was conducted as part of an FDA-approved clinical study at University of Michigan Health and marks a big step for technology that helps people communicate using only their thoughts.
Connexus uses 421 tiny brain wires
Connexus is about the size of a dime and uses 421 tiny wires in the brain to turn thoughts into text or speech, communicating wirelessly through the skin with a transceiver implanted below the left clavicle.
Paradromics will track this patient for 6 years, focusing on safety and how fast and well they can communicate.
They're also hoping this technology could one day help with advanced prosthetics or even mental health treatment.